Guarding the Pharmacy: Compounding’s Impact on the Business of Veterinary Health

About This Episode

Compounding is more than a clinical solution—it’s a powerful driver of client loyalty, compliance, and sustainable practice growth. In this episode, host Dr. Amanda Landis Hannah is joined by Dr. Rae Hutchins, veterinarian and leader at Wedgewood Pharmacy, to explore how compounded medications support personalized patient care while strengthening the business side of veterinary practice. From improving medication adherence to navigating regulatory requirements and choosing high-quality pharmacy partners, this conversation bridges medicine and strategy. Dr. Hutchins shares insights into FDA oversight, the differences between 503A and 503B compounding pharmacies, and how online pharmacy integration—paired with compounding—can increase engagement, recurring revenue, and long-term client trust. Whether you’re facing declining visits, margin pressure, or compliance challenges, this episode offers practical guidance on using compounding as a differentiator that benefits patients, clients, and practice performance. Key Timestamps: Introduction and Guest Background Host Dr. Amanda Landis Hannah introduces the topic of compounding's business impact, noting its benefits for personalized care, overcoming dosage limits, availability issues, and compliance. Dr. Rae Hutchins shares her journey from internal medicine to leadership at Wedgewood Pharmacy, emphasizing her passion for solving clinical problems while supporting practice growth and tying medicine to business success. Power of Personalization and Client Loyalty Compounded medications customize treatments to individual patients and clients, improving outcomes, ease of administration, and adherence in complex cases. This personalization strengthens the human-animal bond, fosters loyalty by showing attentiveness to family dynamics, and keeps clients returning, positioning compounding as a practice-building tool. Regulations, 503A vs 503B, and Pharmacy Selection Compounding faces FDA and state oversight; practices should choose pharmacies compliant with USP standards via audits and quality reporting. 503B facilities produce larger-scale compounds under GMP for office stock, while 503A handles custom patient-specific scripts—both require veterinary-trained pharmacists to ensure safety and efficacy. Brakey Study Insights on Online Pharmacies Pet owners of all generations are comfortable buying medications online and continue to place strong trust in their veterinarians. However, many remain unaware that their practice offers an online pharmacy. Convenience tools such as auto-ship significantly support compliance, while compounding services act as a powerful entry point—driving traffic, strengthening client relationships, and increasing recurring revenue. Evaluating Pharmacies and Business Economics Vet-specific training, CE resources, protocols for adverse events, and online platforms signal quality pharmacies. Amid declining visits and patient-specific shifts, compounding combats margin erosion by boosting engagement, oversight of prescriptions, and recurring revenue through loyalty and e-commerce integration.